Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.480
+0.010 (0.22%)
At close: Jun 26, 2026, 4:00 PM EDT
4.740
+0.260 (5.81%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Cytek Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Cytek Biosciences stock have an average target of 5.69, with a low estimate of 4.75 and a high estimate of 7.50. The average target predicts an increase of 27.01% from the current stock price of 4.48.
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for Cytek Biosciences stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens | Stephens | Buy Reiterates $4.75 | Buy | Reiterates | $4.75 | +6.03% | May 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | +22.77% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7.5 | Buy | Maintains | $7.5 | +67.41% | May 8, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $5 | Hold | Maintains | $5 | +11.61% | May 8, 2026 |
Financial Forecast
Revenue This Year
208.83M
from 201.49M
Increased by 3.64%
Revenue Next Year
222.67M
from 208.83M
Increased by 6.63%
EPS This Year
-0.04
from -0.31
EPS Next Year
0.19
from -0.04
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 209.7M | 225.8M | |
| Avg | 208.8M | 222.7M | |
| Low | 208.0M | 215.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.1% | 8.1% | |
| Avg | 3.6% | 6.6% | |
| Low | 3.2% | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.04 | 0.19 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.